NASDAQ NMS - GLOBAL MARKET · RKTO
-5.32% · -$0.0400 · Vol 318.5K
After hours · updated 17:51:48 ET
Hoth Therapeutics Inc

Hoth Therapeutics Inc

Pharmaceuticals
$0.7480
Card
Relationship Map

Follow $RKTO

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $RKTO by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
RKTO
Hoth Therapeutics Inc
Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is RKTO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RKTO catalysts
About Hoth Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
3
Country
US

Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8099
Day high
$0.8345
Day low
$0.7487
Previous close
$0.7900
52W high
$2.22
-66.31% from high
52W low
$0.6406
7% of range
Market cap
$19.7M
EPS
$-0.7600
Beta
1.13
Shares out
24.9M
Volume
318.5K
0.77× rel vol
Avg volume
415.8K
VWAP
$0.7892
Price history computed in-house
1W
+11.48%
1M
+0.35%
3M
-27.38%
SMA 50 $0.7659 · below
SMA 200 Not reported · Not reported
52W position 7%

RKTO overview

Loading financial statements
Loading RKTO Form 4 filings
Public disclosures

Congress activity in RKTO

No receipt-qualified Congressional disclosure is present for RKTO in the cached public ledger.

Federal contracts

RKTO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RKTO in this window.
Lobbying spend

RKTO lobbying filings, year to date.

Registered lobbying filings matched to Hoth Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RKTO in this window.
Loading news for RKTO
Analyst ratings
Sovereign unlock shows live analyst consensus for RKTO.
Options
Sovereign unlock shows live options positioning for RKTO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.